Post-marketing study of biosimilar infliximab (CT-P13) to evaluate its safety and efficacy in Korea

Sang Hyoung Park, Young Ho Kim, Ji Hyun Lee, Hyeok Jin Kwon, Suck Ho Lee, Dong Il Park, Hyung Kil Kim, Jae Hee Cheon, Jong Pil Im, You Sun Kim, Sung Young Lee, Sang Joon Lee

Research output: Contribution to journalArticlepeer-review

84 Citations (Scopus)

Fingerprint Dive into the research topics of 'Post-marketing study of biosimilar infliximab (CT-P13) to evaluate its safety and efficacy in Korea'. Together they form a unique fingerprint.

Medicine & Life Sciences